$AZN
Market Cap:
$AZN SEC Filings
| Filing | Filed On |
|---|---|
| LYNPARZA? APPROVED IN THE EUROPEAN UNION | 18 Dec 2014 |
| MOVENTIG APPROVED IN THE EU FOR OIC | 09 Dec 2014 |
| JURY VERDICT FAVOURS AZ IN NEXIUM LITIGATION | 05 Dec 2014 |
| NEW DRUG APPLICATION FOR IRESSA ACCEPTED BY US FDA | 02 Dec 2014 |
| BLOCKLISTING INTERIM REVIEW | 01 Dec 2014 |
| TOTAL VOTING RIGHTS | 01 Dec 2014 |
| PUBLICATION OF FINAL TERMS | 24 Nov 2014 |
| DUAKLIR GENUAIR APPROVED IN THE EU FOR COPD | 24 Nov 2014 |
| LAUNCH AND PRICING OF A ?750M BOND | 19 Nov 2014 |
| AZ STRATEGY ON TRACK TO DELIVER GROWTH AND VALUE | 18 Nov 2014 |
| PUBLICATION OF SUPPLEMENTARY PROSPECTUS | 17 Nov 2014 |
| AMGEN & AZ POSITIVE PHASE III BRODALUMAB RESULTS | 12 Nov 2014 |
| DIRECTOR/PDMR SHAREHOLDING | 10 Nov 2014 |
| 3RD QUARTER RESULTS | 06 Nov 2014 |
| 3RD QUARTER RESULTS | 06 Nov 2014 |
| ASTRAZENECA TO DIVEST MYALEPT TO AEGERION | 06 Nov 2014 |
| NOTICE OF RESULTS | 05 Nov 2014 |
| MEDIMMUNE ACQUIRES DEFINIENS | 04 Nov 2014 |
| TOTAL VOTING RIGHTS | 03 Nov 2014 |
| AZ COMPLETES STRATEGIC TRANSACTION WITH ALMIRALL | 03 Nov 2014 |
